This grant is for the purpose of funding innovative research aimed at strengthening and advancing COVID-19 health equity. Specifically, proposals should focus on increasing racial and ethnic minority participation in COVID-19 clinical trials, evaluating the safety and efficacy of FDA-approved or EUA products for COVID-19 treatment and prevention, and analyzing outcomes based on demographic data such as ethnicity, race, age, disability, and geography. The award also seeks research that explores diverse patient perspectives, preferences, and unmet needs concerning COVID-19. This initiative supports critical research to address health disparities in the ongoing pandemic response, ensuring equitable outcomes and informed public health strategies.
Opportunity ID: 335893
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-22-003 |
| Funding Opportunity Title: | Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Consumer Protection Food and Nutrition Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 27, 2021 |
| Last Updated Date: | Sep 27, 2021 |
| Original Closing Date for Applications: | Nov 29, 2021 |
| Current Closing Date for Applications: | Nov 29, 2021 |
| Archive Date: | Dec 29, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $200,000 |
Eligibility
| Eligible Applicants: | Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses |
| Additional Information on Eligibility: | Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationThe following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education:o Hispanic-serving Institutionso Historically Black Colleges and Universities (HBCUs)o Tribally Controlled Colleges and Universities (TCCUs)o Alaska Native and Native Hawaiian Serving Institutionso Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)Nonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)For-Profit OrganizationsSmall BusinessesFor-Profit Organizations (Other than Small Businesses)OtherIndependent School DistrictsPublic Housing Authorities/Indian Housing AuthoritiesNative American Tribal Organizations (other than Federally recognized tribal governments)Faith-based or Community-based OrganizationsRegional Organizations |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance COVID-19 health equity research. Areas of interest include: Proposals that focus on advancing racial and ethnic minority participation in COVID-19/COVID-19 variant clinical trials and/or contribute to informing the continued evaluation of the safety and efficacy of FDA approved products (therapeutics, diagnostics, and vaccines) or products subject to EUAs/EUA expansion for the treatment, prevention, or diagnosis of COVID-19. Proposals that support the evaluation of outcomes by demographic data including, but not limited to, ethnicity, race, age, disability, and geography. Proposals that support COVID-19 research to understand diverse patient perspectives, preferences, and unmet needs |
| Link to Additional Information: | FULL ANNOUNCEMENT |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shashi Malhotra
Grants Management Specialist Phone 2404027592 Email:shashi.malhotra@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Shashi Malhotra Grants Management Specialist Phone 2404027592 Email: shashi.malhotra@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-22-003 | FORM F | PKG00269109 | Sep 27, 2021 | Nov 29, 2021 | View |
Package 1
Mandatory forms
335893 RR_SF424_2_0-2.0.pdf
335893 PHS398_CoverPageSupplement_4_0-4.0.pdf
335893 RR_OtherProjectInfo_1_4-1.4.pdf
335893 PerformanceSite_2_0-2.0.pdf
335893 RR_KeyPersonExpanded_2_0-2.0.pdf
335893 RR_Budget_1_4-1.4.pdf
335893 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
335893 RR_SubawardBudget30_1_4-1.4.pdf
335893 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
